Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction

References

• Bernatova I, Rigatto KV, Key MP, Morris M. Stress-induced pressor and corticosterone responses in oxytocin-deficient mice. Exp Physiol 2004; 89: 549–557
   PubMed Web of Science ®Google Scholar
• Bielsky IF, Hu S‐B, Szegda KL, Westphal H, Young LJ. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 2004; 29: 483–493
   PubMed Web of Science ®Google Scholar
• Budzikowski AS, Paczwa P, Szczepanska-Sadowska E. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR. Am J Physiol Heart Circ Physiol 1996; 271: H1057–H1064
   Google Scholar
• Bujis RM, Kalsbeck A. Anatomy and physiology of vasopressin pathways: From temperature regulation to corticotrophin-inhibiting neurotransmission. Neurohypophysis. Recent progress of vasopressin and oxytocin research. Elsevier, Amsterdam 1995; 57–65
   Google Scholar
• Burrell LM, Risvanis J, Johnston CI, Naitoh M, Balding LC. Vasopressin receptor antagonism—a therapeutic option in heart failure and hypertension. Exp Physiol 2000; 85: 259S–265S
   Google Scholar
• Carrasco GA, van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463: 235–272
   PubMed Web of Science ®Google Scholar
• Clarke SP, Frasure-Smith N, Lesperance F, Bourassa MG. Psychosocial factors as predictors of functional status at 1 year patients with left ventricular dysfunction. Res Nurs Health 2000; 23: 290–300
   PubMed Web of Science ®Google Scholar
• Curran-Everett D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society. Physiol Genomics 2004; 18: 249–251
   PubMed Web of Science ®Google Scholar
• Demotes-Mainard J, Chauveau J, Rodriguez F, Vincent JD, Paulain DA. Septal release of vasopressin in response to osmotic, hypovolemic and electrical stimulation in rats. Brain Res 1986; 381: 314–321
   PubMed Web of Science ®Google Scholar
• DiBona GF, Jones SJ, Brooks VL. Ang II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 1995; 269: R1189–R1196
   Google Scholar
• Felder RB, Francis J, Zhang Z-H, Wie S-G, Weiss RM, Johnson AK. Heart failure and the brain: New perspectives. Am J Physiol Regul Integr Comp Physiol 2003; 284: R259–R276
   PubMedGoogle Scholar
• Fleet R, Lesperance F, Arsenault A, Gregoire J, Lavoie K, Laurin C, Harel F, Burelle D, Lambert J, Beitman B, Frasure-Smith N. Myocardial perfusion study of panic attacks in patients with coronary artery disease. Am J Cardiol 2005; 96: 1064–1068
   PubMed Web of Science ®Google Scholar
• Francis J, Weiss RM, Wei S-G, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 2001; 281: H2241–H2251
   PubMed Web of Science ®Google Scholar
• Francis J, Zhang Z-H, Weiss RM, Felder R. Neural regulation of the proinflamatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 287: H791–H797
   PubMedGoogle Scholar
• Góźdź A, Szczepanska-Sadowska E, Maśliński W, Kumosa M, Szczepanska K, Dobruch J. Differential expression of vasopressin V1a and V1b receptors mRNA in the brain of renin transgenic TGRmRen(2)27 and Sprague Dawley rats. Brain Res Bull 2003; 59: 399–403
   PubMed Web of Science ®Google Scholar
• Griebel G, Simiand J, Stemmelin J, Serradeil L, Gal C, Steinberg R. The vasopressin V1b receptor as a therapeutic target in stress-related disorders. Curr Drug Targets CNS Neurol Disord 2003; 2: 191–200
   PubMedGoogle Scholar
• Grippo AJ, Beltz TG, Johnson AK. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 2003; 78: 703–710
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Santos CM, Johnson RF, Beltz TG, Martins JB, Felder RB, Johnson AK. Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am J Physiol Heart Circ Physiol 2004; 286: H619–H626
   PubMed Web of Science ®Google Scholar
• Haack D, Möhring J. Vasopressin mediated blood pressure response to intraventricular injection of angiotensin II in the rat. Pflügers Arch 1978; 373: 167–173
   PubMed Web of Science ®Google Scholar
• Higa KT, Mori E, Viana FF, Morris M, Michelini LC. Baroreflex control of heart rate by oxytocin in the solitary-vagal complex. Am J Physiol Regul Integr Comp Physiol 2002; 282: R537–R545
   PubMed Web of Science ®Google Scholar
• Holmes A, Heilig M, Rupniak NMJ, Steckler T, Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 2003; 24: 580–588
   PubMed Web of Science ®Google Scholar
• Kario K, McEwen BS, Pickering TG. Disasters and the heart: A review of the effects of earthquake induced stress on cardiovascular disease. Hypertens Res 2003; 26: 355–367
   PubMed Web of Science ®Google Scholar
• Lampert R, Jain D, Burg MM, Batsford WP, McPherson CA. Destabilizing effects of mental stress on ventricular arrhythmia in patients with implantable cardioverter-defibrillators. Circulation 2000; 101: 158–164
   PubMedGoogle Scholar
• Landgraf R. HAB/LAB rats: An animal model of extremes in trait anxiety and depression. Clin Neurosci Res 2003; 3: 239–244
   Google Scholar
• Leenen FHH, Yuan B, Huang BS. Brain “ouabain” and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 1999; 277: H1786–H1792
   Google Scholar
• Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049–1053
   PubMed Web of Science ®Google Scholar
• Łoń S, Szczepańska-Sadowska E, Szczypaczewska M. Evidence that centrally released arginine vasopressin is involved in central pressor action of angiotensin II. Am J Physiol Heart Circ Physiol 1996; 270: H167–H173
   Google Scholar
• Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994; 28: 303–311
   PubMed Web of Science ®Google Scholar
• Manning M, Stoev S, Bankowski K, Misicka A, Lammek B, Wo NC, Sawyer WH. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine vasopressin. J Med Chem 1992; 35: 382–388
   PubMed Web of Science ®Google Scholar
• Muders F, Riegger GA, Bahner U, Palkovits M. The central vasopressinergic system in experimental left ventricular hypertrophy and dysfunction. Prog Brain Res 2002; 139: 275–279
   PubMedGoogle Scholar
• Ono K, Matsumori A, Shioi T, Furokawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 1998; 98: 149–156
   PubMed Web of Science ®Google Scholar
• Paczwa P, Budzikowski AS, Szczepanska-Sadowska E. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial NG-nitro-l-arginine. Brain Res 1997; 748: 51–61
   PubMedGoogle Scholar
• Paczwa P, Szczepańska-Sadowska E, łoń S, Ganten U, Ganten D. Role of central AT1 and V1 receptors in cardiovascular adaptation to hemorrhage in SD and renin TGR rats. Am J Physiol Heart Circ Physiol 1999; 276: H1918–H1926
   Google Scholar
• Pardy K, Murphy D, Carter D, Hui KM. The influence of interleukin-2 on vasopressin and oxytocin gene expression in the rodent hypothalamus. J Neuroimmunol 1993; 42: 131–138
   PubMedGoogle Scholar
• Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996; 53: 137–143
   PubMed Web of Science ®Google Scholar
• Rascher W, Lang RE, Unger T, Ganten D, Gross F. Vasopressin in brain of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 1982; 242: H496–H499
   PubMed Web of Science ®Google Scholar
• Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960; 11: 398–407
   PubMedGoogle Scholar
• Sladek CD, Devine MA, Felten SY, Aravich PF, Blair ML. Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat. Brain Res 1988; 445: 39–46
   PubMed Web of Science ®Google Scholar
• Stępniakowski K, Budzikowski A, Łoń S, Szczepańska-Sadowska E. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst 1994; 47: 33–43
   PubMedGoogle Scholar
• Swords BH, Wyss JM, Berecek KH. Central vasopressin receptors are upregulated by deoxycorticosterone acetate. Brain Res 1991; 559: 10–16
   PubMed Web of Science ®Google Scholar
• Szczepanska-Sadowska E, Gray D, Simon-Opperman C. Vasopressin in blood and third ventricle aCSF during dehydration, thirst, and hemorrhage. Am J Physiol Regul Comp Physiol 1983; 245: R549–R555
   PubMedGoogle Scholar
• Szczepanska-Sadowska E, Paczwa P, Łoń S, Ganten D. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats. J Hypertens 1998; 16: 1505–1514
   PubMed Web of Science ®Google Scholar
• Veltmar A, Culman J, Quadri F, Rascher W, Unger T. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther 1992; 263: 1253–1260
   PubMed Web of Science ®Google Scholar
• Wigger A, Sanchez MM, Mathys KC, Ebner K, Frank E, Liu D, Kresse A, Neumann ID, Holsboer F, Plotsky PM, Landgraf R. Alterations in central neuropeptide expression, release and receptor binding in rats bred for high anxiety: Critical role of vasopressin. Neuropsychopharmacology 2004; 29: 1–14
   PubMed Web of Science ®Google Scholar
• Wilkinson MF, Horn TF, Kasting NW, Pittman QJ. Central interleukin-1 beta stimulation of vasopressin release in the rat brain: Activation of an antipyretic pathway. J Physiol 1994; 481: 641–646
   PubMedGoogle Scholar
• Zhang W, Huang BS, Leenen FH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 1999; 276: H1608–H1615
   Web of Science ®Google Scholar
• Zhang Z-H, Francis J, Weiss RM, Felder RB. The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 2002; 283: H423–H433
   Google Scholar
• Zhu G-Q, Gao L, Li V, Patel KP, Zucker IH, Wang W. AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H1828–H1835
   Google Scholar